Multiple Sclerosis News

June 13, 2025

Top Headlines

AI Tool Can Track Effectiveness of Multiple Sclerosis Treatments

Apr. 7, 2025 — A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been ...

How Cells Respond to Stress Is More Nuanced Than Previously Believed

Mar. 26, 2025 — The body's cells respond to stress -- toxins, mutations, starvation or other assaults -- by pausing normal functions to focus on conserving energy, repairing damaged components and boosting defenses. If the stress is manageable, cells resume normal ...

Nasal Spray Shows Preclinical Promise for Treating Traumatic Brain Injury

Feb. 27, 2025 — A new study suggests a nasal spray developed to target neuroinflammation could one day be an effective treatment for traumatic brain injury (TBI). By studying the effects of the nasal anti-CD3 in a mouse model of TBI, researchers found the spray ...

Multiple Sclerosis: Cell-Catching Implant Helps Identify Successful Treatment in Mice

Feb. 18, 2025 — A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative condition similar to multiple sclerosis in humans. It also gave researchers a look at how primary ...

How Do MS Drugs Affect Pregnancy?

Dec. 18, 2024 — Many women are diagnosed with multiple sclerosis (MS) at an age when they are considering starting a family. What does the disease and its medication mean for the child? To answer this question, a research team analyzed over 3,700 pregnancies of ...

Molecular Zip Code Draws Killer T Cells Straight to Brain Tumors

Dec. 5, 2024 — Scientists have developed a 'molecular GPS' to guide immune cells into the brain and kill tumors without harming healthy ...

Multiple Sclerosis Drug May Help With Poor Working Memory

Nov. 18, 2024 — Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in mental health conditions like schizophrenia or ...

Ancient Viral DNA in the Human Genome Linked to Multiple Sclerosis and Amyotrophic Lateral Sclerosis

Oct. 21, 2024 — New research has revealed a connection between ancient viral DNA embedded in the human genome and the genetic risk for two major diseases that affect the central nervous ...

A New Era of Treating Neurological Diseases at the Blood-Brain-Immune Interface

Oct. 17, 2024 — A group of scientists say it's time to think differently about how to define and treat diseases such as Alzheimer's and multiple ...

For Multiple Sclerosis, Medication and Cognitive Behavioral Therapy Can Reduce Fatigue

Oct. 17, 2024 — In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in significant improvements in fatigue. Researchers ...

New Study Finds a Promising Combined Therapy for Multiple Sclerosis

Oct. 2, 2024 — Researchers have found a potential new way to improve the treatment of multiple sclerosis (MS) using a novel combined therapy. The results build on two harmonized Phase I clinical trials, focusing on the use of Vitamin D3 tolerogenic dendritic cells ...

Molecular Mechanism Behind MS and Other Autoimmune Diseases

Aug. 28, 2024 — More than two decades ago, a research team discovered a type of T cell in humans that suppresses the immune system; they later found that these so-called regulatory T cells, when defective, are an underlying cause of autoimmune disease, specifically ...

Latest Headlines

updated 12:11pm EDT

Multiple Sclerosis Appears to Protect Against Alzheimer's Disease

Aug. 23, 2024 — A collaborative investigation among experts in Alzheimer's disease and multiple sclerosis (MS) finds evidence that MS patients are less likely to have amyloid plaques, a hallmark of Alzheimer's ...

Epstein-Barr Virus and Brain Cross-Reactivity: Possible Mechanism for Multiple Sclerosis

June 6, 2024 — The role that Epstein-Barr Virus (EBV) plays in the development of Multiple Sclerosis may be caused a higher level of cross-reactivity, where the ...

Mechanisms for Selective Multiple Sclerosis Treatment Strategy

May 28, 2024 — Researchers have demonstrated how B cells infected with the Epstein-Barr virus (EBV) can contribute to a pathogenic, inflammatory phenotype that contributes to multiple sclerosis (MS); the group has ...

Flicker Stimulation Shines in Clinical Trial for Epilepsy

May 22, 2024 — Researcher leads a new clinical trial testing her flicker technology on patients with ...

For Immigrants to Canada, Risk of Multiple Sclerosis Increases With Proportion of Life Spent There, Study Finds

Apr. 24, 2024 — Immigrants to Canada who have spent a greater proportion of their lives in Canada have a greater risk of developing multiple sclerosis (MS) than ...

Common Household Chemicals Pose New Threat to Brain Health, Study Finds

Mar. 25, 2024 — Researchers have provided fresh insight into the dangers some common household chemicals pose to brain health. They suggest that chemicals found in a wide range of items, from furniture to hair ...

Research Offers Hope for Preventing Post-COVID 'Brain Fog' by Targeting Brain's Blood Vessels

Mar. 21, 2024 — Researchers have identified a mechanism that causes neurological problems in mice infected with SARS-CoV-2, the virus behind COVID-19. The ...

Cellular Architecture of Lesions in Multiple Sclerosis Now Mapped out

Mar. 20, 2024 — Using advanced methodology, scientists have been able to reveal at the cellular level how lesions in multiple sclerosis ...

Fixing Rogue Brain Cells May Hold Key to Preventing Neurodegeneration

Feb. 20, 2024 — Scientists have identified a new therapeutic approach for combating neurodegenerative diseases, offering hope of improved treatments for Alzheimer's disease, Parkinson's disease, Vanishing White ...

Analysis of Biological Networks Helps Explain the Complexity of Multiple Sclerosis

Feb. 8, 2024 — An international study has used a computational biology tool that, by analyzing a multitude of biological data from multiple sclerosis patients ...

Can a Computer Tell Patients How Their Multiple Sclerosis Will Progress?

July 25, 2024 — Machine learning models can reliably inform clinicians about the disability progression of multiple sclerosis, according to a new study published this week in the open-access journal PLOS Digital ...

Ancient DNA Reveals Reason for High Multiple Sclerosis and Alzheimer's Rates in Europe

Jan. 10, 2024 — Researchers have created the world's largest ancient human gene bank by analyzing the bones and teeth of almost 5,000 humans who lived across western Europe and Asia up to 34,000 years ago. By ...

Severe MS Predicted Using Machine Learning

Jan. 9, 2024 — A combination of only 11 proteins can predict long-term disability outcomes in multiple sclerosis (MS) for different individuals. The identified proteins could be used to tailor treatments to the ...

Study Reveals a Protein Called Snail May Play a Role in Healing Brain Injury

Dec. 11, 2023 — A new study provides us with a better understanding of how the brain responds to injuries. Researchers have discovered that a protein called Snail plays a key role in coordinating the response of ...

Potential New Drug Treatment for Multiple Sclerosis

Dec. 8, 2023 — Pre-clinical studies using a small molecule drug have shown promise as a potential new treatment for multiple sclerosis ...

A Blood Test Shows MS Worsening 1 to 2 Years Before It Happens

Nov. 6, 2023 — Multiple sclerosis patients whose blood tests reveal elevated NfL, a biomarker of nerve damage, could see worsening disability one to two years later, according to a new ...

Depression, Anxiety May Be Among Early Signs of MS

Sep. 25, 2023 — New research is painting a clearer picture of the early signs of multiple sclerosis (MS), showing that people are nearly twice as likely to experience mental illness in the years leading up to the ...

Marker for Brain Inflammation Finally Decoded

Sep. 25, 2023 — Inflammation is the sign that our body is defending itself against an aggression. But when this response escalates, for example in the brain, it can lead to serious neurological or psychiatric ...

Possible Biomarker of MS-Like Autoimmune Disease Discovered

Aug. 8, 2023 — It has been known for several years that the diagnosis 'multiple sclerosis' conceals a whole range of different illnesses, each requiring customized treatment. Researchers have now ...

Treatment at the First Signs of MS Could Mean Lower Risk of Disability Later

July 19, 2023 — People who start taking medication soon after the first signs of multiple sclerosis (MS) may have a lower risk of disability later, according to a new ...

Oral Medication Is the Leading Choice for Multiple Sclerosis Treatment

July 12, 2023 — Two injectable therapies accounted for nearly 100 percent of medications for patients in 2001, but by 2020 that decreased to about 25 ...

Multiple Sclerosis: New Biomarker Confirmed for Early Diagnosis

July 6, 2023 — A study has demonstrated for the first time that diagnosis of multiple sclerosis (MS) can be significantly improved by additionally measuring the thickness of retinal layers in the eye. Use of the ...

Genetic Variant Linked With Faster Progression of Multiple Sclerosis

June 28, 2023 — A study of more than 22,000 people with multiple sclerosis (MS) has for the first time identified a genetic variant associated with faster progression of the disease, an accumulation of disability ...

What Makes Multiple Sclerosis Worse, and How to Make It Better

June 28, 2023 — Scientists identify the first genetic marker for MS severity, opening the door to preventing long-term ...

Pregnancy Hormone Repairs Myelin Damage in MS Mouse Model

June 15, 2023 — A new study has identified a treatment that could repair myelin in the cortex, undoing some of the damage caused by ...

Can This Medication Reverse MS? Brain Biomarker Shows It Can

June 12, 2023 — A decade after scientists identified an over-the-counter antihistamine as a treatment for multiple sclerosis, researchers have developed an approach to measure the drug's effectiveness in ...

Children at Risk of Multiple Sclerosis Often Go Undetected in Early Stages

Mar. 16, 2023 — Criteria used by neurologists to assess for multiple sclerosis (MS) in adults may fail to identify the illness in children with imaging suspicious for the disease, an oversight that could delay ...

First Nasal Monoclonal Antibody Treatment for COVID-19 Shows Promise for Treating Virus, Other Diseases

Mar. 8, 2023 — A pilot trial tested the nasal administration of the drug Foralumab, an anti-CD3 monoclonal antibody. Investigators found evidence that the drug dampened the inflammatory T cell response and ...

Researcher Takes Another Step Toward Discovering How a Brain Molecule Could Halt MS

Feb. 1, 2023 — A researcher is one step closer to demonstrating the potential of a brain molecule called fractalkine to halt and even reverse the effects of multiple sclerosis and other neurodegenerative diseases. ...

Stem Cell Transplants May Delay Disability Longer Than Some MS Medications

Dec. 21, 2022 — In people with active secondary progressive multiple sclerosis (MS), hematopoietic stem cell transplants may delay disability longer than some other MS medications, according to a new study. The ...